MD1365G2 - Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer - Google Patents
Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer Download PDFInfo
- Publication number
- MD1365G2 MD1365G2 MD99-0035A MD990035A MD1365G2 MD 1365 G2 MD1365 G2 MD 1365G2 MD 990035 A MD990035 A MD 990035A MD 1365 G2 MD1365 G2 MD 1365G2
- Authority
- MD
- Moldova
- Prior art keywords
- appearing
- bone metastasis
- vir
- tpc
- months
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title abstract 5
- 210000000988 bone and bone Anatomy 0.000 title abstract 5
- 230000009401 metastasis Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 210000005075 mammary gland Anatomy 0.000 title abstract 2
- 238000009096 combination chemotherapy Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention refers to medicine, in particular, to the oncology.Summary of the method consists in that one points out parameters which characterize the mammary gland cancer initial process (SP), primary hotbed (MF) and local-regional lymphoglandula (MG) morphology, nonspecific bone system pathology (PN), initial process specific treatment regimen (TS), patient age (VIR), initial process polychemotherapy regimen (PC), polychemotherapy type (TPC), one carries out an evaluation of obtained parameters in the form of quantitative values, thereafter one calculates a prognostical effect F1, showing the time of appearing the bone metastasis during 6 months and F2, showing the time of appearing the bone metastasis more than in 6 months according to the formulas:F1=1,878×SP+1,390×MF+1,512×MG+1,687×PN+5,332×TS+0,706×VIR+0,063×PC+1,236×TPC-27,225;F2=1,982×SP+1,968×MF+0,835×MG+3,226×PN+6,45×TS+0,746×VIR-0,690×PC+3,230×TPC-31,803and if F1 is greater then F2 one prognosticates metastasis appearing during 6 months.The result consists in selection of informative parameters which characterize the time of appearing the bone metastasis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD99-0035A MD1365G2 (en) | 1999-01-21 | 1999-01-21 | Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD99-0035A MD1365G2 (en) | 1999-01-21 | 1999-01-21 | Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1365F1 MD1365F1 (en) | 1999-12-31 |
| MD1365G2 true MD1365G2 (en) | 2000-07-31 |
Family
ID=19739311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD99-0035A MD1365G2 (en) | 1999-01-21 | 1999-01-21 | Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1365G2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (en) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prognosticating the risk of development of nosocomial septico-purulent infections |
-
1999
- 1999-01-21 MD MD99-0035A patent/MD1365G2/en unknown
Non-Patent Citations (1)
| Title |
|---|
| Кутателадзе Т.О. Метастатические опухоли костей. Современные методы диагностики, лечения и прогноз. Автореферат. дисс. доктора мед. наук, Москва, 1991, с. 13-14, 41, 43 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (en) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prognosticating the risk of development of nosocomial septico-purulent infections |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1365F1 (en) | 1999-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1503299A (en) | Virtual orthodontic treatment | |
| IL150258A0 (en) | Cascade polymer complexes | |
| DE69531457D1 (en) | Sulfonamide | |
| GB0109146D0 (en) | Treatment of type 2 diabetes | |
| AU8384901A (en) | Method and apparatus for displaying information obtained by electrical impedancetomography data | |
| CY2473B1 (en) | New phenanthridines. | |
| DE60001564D1 (en) | BICYCLIC POLYAMIOUS METAL COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR MEDICAL IMAGE GENERATION | |
| NZ294446A (en) | Stem cell proliferation inhibitors, haemoglobin chains used for the treatment of autoimmune diseases. | |
| TW328575B (en) | Register set reordering for a graphics processor based upon the type of primitive be rendered | |
| PT827537E (en) | Chromatin-regulator genes | |
| WO2004105574A3 (en) | Image guided radiation therapy | |
| MD2196B2 (en) | Cryptophycins, process for obtaining, pharmaceutical compositions on base thereof, method of inhibiting the proliferation of the mammal cells and method of attenuating the pathological state caused by hyperproliferation of mammal cells | |
| CA2319119A1 (en) | Cerebral circulation model and applications | |
| MD1365G2 (en) | Method of prognostication of bone metastasis appearing at patients affected with mammary gland cancer | |
| DK0821588T3 (en) | Levobupivacaine and its use as an anesthetic for pregnant women | |
| GR3034155T3 (en) | Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer | |
| KR960702756A (en) | METHOD FOR DIFFUSING AN ODORIFEROUS SUBSTANCE | |
| AU2003229876A1 (en) | Tumour associated antigens | |
| GEP20032883B (en) | Method for Bioenergography | |
| UA23907A (en) | Method for diagnostics of quality of remission at schizophrenia | |
| MD581G2 (en) | Method of prognosis of the left ventricle postinfarct aneurysm | |
| NO961817D0 (en) | Chemical pulp bleaching process | |
| JPS52144943A (en) | Information introduction system in the health insurance doctor point calculator | |
| UA38590A (en) | Method for treating glomerulonephritis with anephrotic syndrome and hematuric component | |
| EP1321146A3 (en) | Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD99 | Pending application |